Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.68 EUR
−594.00 M EUR
22.30 B EUR
411.09 M
About FRESENIUS SE+CO.KGAA O.N.
Sector
Industry
CEO
Michael Sen
Website
Headquarters
Bad Homburg
Founded
2011
ISIN
DE0005785604
FIGI
BBG00HL0TNP9
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4FRE is 33.86 EUR — it has increased by 0.75% in the past 24 hours. Watch FRESENIUS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange FRESENIUS stocks are traded under the ticker 4FRE.
4FRE stock has risen by 0.48% compared to the previous week, the month change is a −1.15% fall, over the last year FRESENIUS has showed a 15.52% increase.
We've gathered analysts' opinions on FRESENIUS future price: according to them, 4FRE price has a max estimate of 44.00 EUR and a min estimate of 30.00 EUR. Watch 4FRE chart and read a more detailed FRESENIUS stock forecast: see what analysts think of FRESENIUS and suggest that you do with its stocks.
4FRE reached its all-time high on Jul 12, 2017 with the price of 76.60 EUR, and its all-time low was 19.87 EUR and was reached on Oct 13, 2022. View more price dynamics on 4FRE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4FRE stock is 1.03% volatile and has beta coefficient of 0.33. Track FRESENIUS stock price on the chart and check out the list of the most volatile stocks — is FRESENIUS there?
Today FRESENIUS has the market capitalization of 18.82 B, it has decreased by −1.71% over the last week.
Yes, you can track FRESENIUS financials in yearly and quarterly reports right on TradingView.
FRESENIUS is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
4FRE earnings for the last quarter are 0.69 EUR per share, whereas the estimation was 0.65 EUR resulting in a 5.54% surprise. The estimated earnings for the next quarter are 0.68 EUR per share. See more details about FRESENIUS earnings.
FRESENIUS revenue for the last quarter amounts to 5.30 B EUR, despite the estimated figure of 5.21 B EUR. In the next quarter, revenue is expected to reach 5.41 B EUR.
4FRE net income for the last quarter is 326.00 M EUR, while the quarter before that showed −373.00 M EUR of net income which accounts for 187.40% change. Track more FRESENIUS financial stats to get the full picture.
As of Dec 3, 2024, the company has 193.87 K employees. See our rating of the largest employees — is FRESENIUS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESENIUS EBITDA is 2.99 B EUR, and current EBITDA margin is 12.44%. See more stats in FRESENIUS financial statements.
Like other stocks, 4FRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESENIUS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESENIUS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESENIUS stock shows the buy signal. See more of FRESENIUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.